Deadline: October 21, 2016
The Consortium Collaborative Pilot Project Award is a joint program of the Duke Clinical and Translational Science Institute (CTSI) and the North Carolina Translational and Clinical Sciences Institute. The program is funded at each institution through the National Institutes of Health’s Clinical and Translational Science Award (CTSA).
This pilot program will fund up to $25,000 per institution for a total of $50,000 per collaborative project that facilitates novel clinical and translational research that applies or accelerates discovery into testing in clinical or population settings. Projects must demonstrate high translational potential with a clear path to subsequent grant support, new company formation, licensing, not-for-profit partnering, or other channels. Population health improvement projects should demonstrate significant stakeholder involvement to move them more globally into broader practice patterns, clinical guidelines, and other applications.
This TI/T2 pilot program is designed to encourage and facilitate novel clinical adn translational research that applies or accelerates discovery into testing in clinical or population settings.
Proposed projects must involve a lead investigator from Duke and a lead investigator from UNC-CH. Proposals are encouraged from new teams of investigators from different disciplines. Applicants at each institution must have a full-time faculty appointment.
Interested investigators who need assistance identifying collaborators at Duke or UNC-CH can use the Reach NC tool or contact either Duke CTSI (email@example.com) or NC TraCS (firstname.lastname@example.org) for assistance.
Proposal should be submitted via the MyResearchProposal online system.